| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.114222.4.11.7242/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7242 |
| Version | 20200807 |
| Status | active |
| Date | 2020-08-07T01:00:27-04:00 |
| Name | NHSNCdiffTestMethod |
| Title | NHSNCdiffTestMethod |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: NHSN surveillance reporting: Testing details for C. difficile),(Data Element Scope: An observation value that represents the primary testing method for C. difficile that is used most often for this quarter by the facility's laboratory or by the outside laboratory where the facility's testing is performed.),(Inclusion Criteria: ),(Exclusion Criteria: ) |
No resources found
| CodeSystem | |
https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html  | NHSN Surveillance System Codes |
| https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html | NHSN Surveillance System Codes |
| https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html | NHSN Surveillance System Codes |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.114222.4.11.7242",
"meta" : {
"versionId" : "5",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "CDC NHSN Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-02-07"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2020-08-07"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7242",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.114222.4.11.7242"
}
],
"version" : "20200807",
"name" : "NHSNCdiffTestMethod",
"title" : "NHSNCdiffTestMethod",
"status" : "active",
"experimental" : false,
"date" : "2020-08-07T01:00:27-04:00",
"publisher" : "CDC NHSN",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: NHSN surveillance reporting: Testing details for C. difficile),(Data Element Scope: An observation value that represents the primary testing method for C. difficile that is used most often for this quarter by the facility's laboratory or by the outside laboratory where the facility's testing is performed.),(Inclusion Criteria: ),(Exclusion Criteria: )",
"compose" : {
"include" : [
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"concept" : [
{
"code" : "2030-5",
"display" : "Enzyme immunoassay (EIA) for toxin"
},
{
"code" : "2031-3",
"display" : "Cell cytotoxicity neutralization assay"
},
{
"code" : "2032-1",
"display" : "Nucleic acid amplification test (NAAT)"
},
{
"code" : "2033-9",
"display" : "Glutamate dehydrogenase (GDH) antigen plus enzyme immunoassay (EIA) for toxin"
},
{
"code" : "2034-7",
"display" : "Glutamate dehydrogenase (GDH) plus nucleic acid amplification test (NAAT)"
},
{
"code" : "2035-4",
"display" : "Glutamate dehydrogenase (GDH) plus enzyme immunoassay (EIA) for toxin, followed by nucleic acid amplification test (NAAT) for discrepant results"
},
{
"code" : "2036-2",
"display" : "Toxigenic culture"
},
{
"code" : "2057-8",
"display" : "Nucleic acid amplification test (NAAT) plus enzyme immunoassay (EIA), if NAAT positive (2-step algorithm)"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:acbd28a2-77a2-4296-8cfa-d998cffa5a06",
"timestamp" : "2024-12-10T11:56:19-05:00",
"total" : 8,
"contains" : [
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2030-5",
"display" : "Enzyme immunoassay (EIA) for toxin"
},
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2031-3",
"display" : "Cell cytotoxicity neutralization assay"
},
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2032-1",
"display" : "Nucleic acid amplification test (NAAT)"
},
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2033-9",
"display" : "Glutamate dehydrogenase (GDH) antigen plus enzyme immunoassay (EIA) for toxin"
},
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2034-7",
"display" : "Glutamate dehydrogenase (GDH) plus nucleic acid amplification test (NAAT)"
},
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2035-4",
"display" : "Glutamate dehydrogenase (GDH) plus enzyme immunoassay (EIA) for toxin, followed by nucleic acid amplification test (NAAT) for discrepant results"
},
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2036-2",
"display" : "Toxigenic culture"
},
{
"system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
"version" : "2023-04",
"code" : "2057-8",
"display" : "Nucleic acid amplification test (NAAT) plus enzyme immunoassay (EIA), if NAAT positive (2-step algorithm)"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.